8:30-10:30 -
MONDAY, 10 SEPTEMBER, 2007 (Concurrent Sessions WFN & IHA)
Hall 1, Hall 4 and Meeting Room 1
8:30-10:30
Scientific Session I: Pathogenesis and Pathophysiology of HD I
Chairs:Marcy MacDonald (Boston, USA), Stefano Di Donato (Milan, Italy)
08:30Shooting the Messenger: siRNA as Treatment in HD?
Beverly Davidson (Iowa City, USA)
09:00Somatic Triplet Repeat Mutation Length Gains in HD Tissues – Relevant for HD?
Gillian P. Bates (London, UK)
09:10Multiple, Structurally and Functionally Distinct Aggregates in Peptide and Cell Models of Huntingtin Exon-1 Behaviour
Ron Wetzel (Pittsburgh, USA)
09:30Polyglutamine: Structural Properties and Toxicity Threshold
Yvon Trottier (Strasbourg, France)
09:50Crystal Structure of the Central Coiled-Coil Domain of Huntingtin-Interacting Protein 1 (HIP1) Reveals a Potential Binding Surface for Huntingtin and HIPPI
Joel A. Ybe (Bloomington, USA)
10:00Chaperones, Neurodegeneration and Chaperonotherapy
Sarah Broadley (Martinsried, Germany)
10:20Identification of Novel Non-Canonical Chaperones of the Hsp40 Family as Very Potent Suppressors of Polyglutamine Proteins in Cell Models and In Vivo Xenopus Model
Harm H. Kampinga (Groningen, The Netherlands)
Clinical Session I: Understanding the Clinical Features of HD
Chairs:Julie Snowden (Manchester, UK), Matthias Dose (Taufkirchen, Germany)
08:30Understanding Basal Ganglia Dysfunction in HD
Anne B. Young (Boston, USA)
09:00Psychopathology in Huntington’s Disease Gene Carriers in Comparison with their Gene-Negative Siblings and the General Population
Erik van Duijn (Leiden, The Netherlands)
09:15Emotion Recognition in Huntington’s Disease
Julie Snowden (Manchester, UK)
09:30Emotion Recognition and its MRI Correlates: Selective Impairment of Anger Recognition in Huntington’s Disease
Susie Henley (London, UK)
09:40Predicting Depression in Pre-HD
Kevin Duff (Iowa, USA)
09:50Obsessive and Compulsive Symptoms in Pre-Diagnosed Huntington’s Disease
Leigh J. Beglinger (Iowa, USA)
10:00Irritability in Presymptomatic Huntington’s Disease
Stefan Klöppel (London, UK)
10:10Behaviour Change in Huntington’s Disease Focused on Aggression
Markus Alexander Lindinger (Graz, Austria)
10:20Clinical Presentation and Biological Changes in Juvenile Huntington’s Disease: Evidence of Dosage Effect of the Mutation
Ferdinando Squitieri (Pozzilli, Italy)
IHA Session I
Chair:Catherine Paradise (Dublin, Ireland)
08:30How People with HD Think, how to Accommodate these Changes and how to More Efficiently Interact with those whom you Love (Part I)
James J. Pollard (Lowell, USA)

Back to Overview
8:30-10:3011:00-13:0014:00-15:3016:00-18:00